Editorial
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Apr 14, 2024; 30(14): 1958-1962
Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.1958
Current status of liver transplantation for human immunodeficiency virus-infected patients in mainland China
Jian-Xin Tang, Dong Zhao
Jian-Xin Tang, Dong Zhao, Department of Liver Surgery and Organ Transplantation Center, Shenzhen Third People’s Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Disease, Shenzhen 518000, Guangdong Province, China
Author contributions: Zhao D contributed to study conception and design, and administrative support; Zhao D and Tang JX contributed to provision of the study materials, and collection and assembly of the data; and all authors contributed to the writing and final approval of the manuscript.
Supported by the Shenzhen Science and Technology R&D Fund, No. JCYJ20220530163011026; and Shenzhen Third People’s Hospital, No. G2022008 and No. G2021008.
Conflict-of-interest statement: No conflict-of-interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Dong Zhao, MD, Chief Doctor, Department of Liver Surgery and Organ Transplantation Center, Shenzhen Third People’s Hospital, The Second Affiliated Hospital of Southern University of Science and Technology, National Clinical Research Center for Infectious Disease, No. 29 Bulan Road, Longgang District, Shenzhen 518000, Guangdong Province, China. zdong1233@126.com
Received: December 28, 2023
Peer-review started: December 28, 2023
First decision: February 9, 2024
Revised: February 18, 2024
Accepted: March 21, 2024
Article in press: March 21, 2024
Published online: April 14, 2024
Processing time: 106 Days and 11.2 Hours
Core Tip

Core Tip: In mainland China, human immunodeficiency virus (HIV) infection has long been considered an absolute contraindication for liver transplantation (LT). Until June 2004, Chinese scholars performed LT on two HIV patients, but these cases were only followed up for 24 and 22 months, respectively. Subsequently, there were no reported cases of LT in mainland China for patients with HIV infection until April 2019, when our transplant center performed ABO-incompatible LT for a patient with liver failure co-infected with HIV and hepatitis B virus. This study provides an overview of the current landscape of HIV-positive patients receiving liver transplantation in mainland China.